Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors - Concepedia

Concepedia

Publication | Closed Access

Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors

80

Citations

19

References

2007

Year

Noboru Yamamoto, Atsushi Horiike, Yasuhito Fujisaka, Haruyasu Murakami, Tatsu Shimoyama, Yasuhide Yamada, Tomohide Tamura

Cancer Chemotherapy and Pharmacology

OncologySolid TumorsMedicinePharmacokinetic StudyCancer GrowthPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyJapanese Patients

References

	Year	Citations

Page 1